Leukemia & Lymphoma, 1029-2403

Tidskrift

Fler filtreringsmöjligheter
  1. Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry.

    Abrahamsson, A., Dahle, N. & Mats Jerkeman, 2011, I : Leukemia & Lymphoma. 52, 10, s. 1929-1935

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma

    Berglund, M., Thunberg, U., Fridberg, M., Gjörloff Wingren, A., Gullbo, J., Leuchowius, K-J., Amini, R-M., Lagercrantz, S., Biloglav, A., Enblad, G. & Soderberg, O., 2007, I : Leukemia & Lymphoma. 48, 5, s. 1038-1041

    Forskningsoutput: TidskriftsbidragLetter

  3. Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study

    Henrik Cederleuf, Hjort Jakobsen, L., Fredrik Ellin, de Nully Brown, P., Stauffer Larsen, T., Bøgsted, M., Relander, T., Mats Jerkeman & El-Galaly, T. C., 2017 dec 2, I : Leukemia and Lymphoma. 58, 12, s. 2815-2823 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

    Delsing Malmberg, E., Johansson Alm, S., Nicklasson, M., Lazarevic, V., Ståhlman, S., Samuelsson, T., Lenhoff, S., Asp, J., Mats Ehinger, Palmqvist, L., Brune, M. & Fogelstrand, L., 2019, I : Leukemia and Lymphoma. 60, 2, s. 409-417

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Clonal evolution to histiocytic sarcoma with the BCR/ABL rearrangement 14 years after acute lymphoblastic leukemia.

    Michael Dictor, Warenholt, J., Gyorgy, C., Månsson, I. & Larsson, G., 2009, I : Leukemia & Lymphoma. 50, s. 1892-1895

    Forskningsoutput: TidskriftsbidragLetter

  6. Single nucleotide polymorphism array analysis of clonal evolution in younger adult acute lymphoblastic leukemia

    Dirse, V., Gineikiene, E., Zvirblis, T., Bertasiute, R., Kajsa Paulsson & Griskevicius, L., 2016, I : Leukemia & Lymphoma. 57, 11, s. 2716-2719 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network

    Dreyling, M., Amador, V., Callanan, M., Mats Jerkeman, Le Goui, S., Pott, C., Rule, S. & Zaja, F., 2015, I : Leukemia & Lymphoma. 56, 4, s. 866-876

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  8. Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations

    Dreyling, M., Aurer, I., Cortelazzo, S., Hermine, O., Hess, G., Mats Jerkeman, Le Gouill, S., Ribrag, V., Trněný, M., Visco, C., Walewski, J., Zaja, F. & Zinzani, P. L., 2018, I : Leukemia and Lymphoma. 59, 8, s. 1814-1828

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma

    Fjordén, K., Joost, P., Mats Ehinger, Patrik Edén, Mats Jerkeman, Cavallin-Ståhl, E. & Linderoth, J., 2012, I : Leukemia & Lymphoma. 53, 9, s. 1764-1768

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

    Fjordén, K., Linderoth, J., Nyman, H., Mats Ehinger, Joost, P., Pär-Ola Bendahl, Leppä, S. & Mats Jerkeman, 2010, I : Leukemia & Lymphoma. 51, s. 1643-1648

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 4 Nästa